<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from (a) Gelman Sciences Inc. Consolidated Statement of Operations and Consolidated Statement of Cash Flows for the six months ended January 31, 1995 and the Consolidated Balance Sheet as of January 31, 1995 and is qualified in its entirety by reference to such (b) Form 10-Q for the second quarter ended January 31, 1995. </LEGEND> <CIK> 0000310252 <NAME> GELMAN SCIENCES INC. <MULTIPLIER> 1,000 <CURRENCY> U.S. DOLLARS <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> JUL-31-1995 <PERIOD-START> AUG-01-1994 <PERIOD-END> JAN-31-1995 <EXCHANGE-RATE> 1 <CASH> 1,906 <SECURITIES> 0 <RECEIVABLES> 22,669 <ALLOWANCES> 989 <INVENTORY> 14,183 <CURRENT-ASSETS> 42,254 <PP&E> 65,552 <DEPRECIATION> 35,252 <TOTAL-ASSETS> 74,902 <CURRENT-LIABILITIES> 18,392 <BONDS> 20,739 <COMMON> 622 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 32,993 <TOTAL-LIABILITY-AND-EQUITY> 74,902 <SALES> 48,185 <TOTAL-REVENUES> 48,185 <CGS> 23,583 <TOTAL-COSTS> 23,583 <OTHER-EXPENSES> 19,704 <LOSS-PROVISION> 118 <INTEREST-EXPENSE> 882 <INCOME-PRETAX> 3,898 <INCOME-TAX> 1,411 <INCOME-CONTINUING> 2,487 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 2,487 <EPS-PRIMARY> .38 <EPS-DILUTED> .38